These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28610451)

  • 1. Cognitive function is largely intact in methadone maintenance treatment patients.
    Elkana O; Adelson M; Doniger GM; Sason A; Peles E
    World J Biol Psychiatry; 2019 Mar; 20(3):219-229. PubMed ID: 28610451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achievement of take-home dose privileges is associated with better-perceived sleep and with cognitive status among methadone maintenance treatment patients.
    Peles E; Schreiber S; Domany Y; Sason A; Tene O; Adelson M
    World J Biol Psychiatry; 2014 Dec; 15(8):620-8. PubMed ID: 24666249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are 2 weeks of "take-home" privileges beneficial for patients' long-term outcome in a methadone maintenance treatment program?
    Adelson M; Schreiber S; Sason A; Peles E
    J Addict Med; 2014; 8(3):170-5. PubMed ID: 24440893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological performance of methadone-maintained opiate users.
    Wang GY; Wouldes TA; Kydd R; Jensen M; Russell BR
    J Psychopharmacol; 2014 Aug; 28(8):789-99. PubMed ID: 24920133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Peles E; Schreiber S; Rados V; Adelson M
    J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics.
    Peles E; Schreiber S; Linzy S; Domani Y; Adelson M
    J Subst Abuse Treat; 2015 Jul; 54():44-9. PubMed ID: 25605438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulsivity and craving in subjects with opioid use disorder on methadone maintenance treatment.
    Li J; Weidacker K; Mandali A; Zhang Y; Whiteford S; Ren Q; Zhou Z; Zhou H; Jiang H; Du J; Zhang C; Sun B; Voon V
    Drug Alcohol Depend; 2021 Feb; 219():108483. PubMed ID: 33385690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting EEG and ERPs findings in methadone-substituted opiate users: a review.
    Wang GY; Kydd R; Russell BR
    Acta Neurol Belg; 2015 Dec; 115(4):539-46. PubMed ID: 25894352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study.
    Mayet A; Lions C; Roux P; Mora M; Maradan G; Morel A; Michel L; Marimoutou C; Carrieri MP
    J Subst Abuse Treat; 2015 Nov; 58():100-5. PubMed ID: 26260134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome unaffected by initiation of full weekend closure of methadone maintenance treatment clinic.
    Peles E; Schreiber S; Adelson M
    J Addict Dis; 2014; 33(2):77-82. PubMed ID: 24717114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in Cognitive Performance after One Year of Methadone Maintenance Treatment.
    Elkana O; Adelson M; Sason A; Doniger GM; Peles E
    Psychiatry Res; 2020 Dec; 294():113526. PubMed ID: 33126016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment.
    Prosser J; Cohen LJ; Steinfeld M; Eisenberg D; London ED; Galynker II
    Drug Alcohol Depend; 2006 Oct; 84(3):240-7. PubMed ID: 16545923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory event-related potentials in methadone substituted opiate users.
    Wang GY; Kydd R; Russell BR
    J Psychopharmacol; 2015 Sep; 29(9):983-95. PubMed ID: 26038111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of the effects of working memory training in methadone maintenance patients.
    Rass O; Schacht RL; Buckheit K; Johnson MW; Strain EC; Mintzer MZ
    Drug Alcohol Depend; 2015 Nov; 156():38-46. PubMed ID: 26404954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life.
    Teoh Bing Fei J; Yee A; Habil MH
    Am J Addict; 2016 Jan; 25(1):49-55. PubMed ID: 26692463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
    Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
    J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users.
    Darke S; McDonald S; Kaye S; Torok M
    Drug Alcohol Depend; 2012 Dec; 126(3):309-15. PubMed ID: 22726911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.